LDC000067 is a highly selective CDK9 inhibitor.

AZD7762 is a potent and selective inhibitor of Chk1.

Rabusertib is an inhibitor of the cell cycle checkpoint kinase 2 (chk2) with potential chemopotentiating activity.

BI2536 is a potent Plk1 inhibitor.

Volasertib is a dihydropteridinone Polo-like kinase 1 (Plk1) inhibitor with potential antineoplastic activity.

Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. 

GSK461364 inhibits purified Plk1.

NSC 23766 is an inhibitor of Rac GTPase.